Drug Trial Radar · NCT02654171
Viral Inhibition in Children for Treatment of RSV
Last checked: Nov 20, 2026Latest source record: Feb 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
72
Actual
Start
May 27, 2016
Primary completion
Mar 31, 2019
Study completion Apr 9, 2019
Sponsor
- Lead sponsor
- Shanghai Ark Biopharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- Collaborators
- Ark Biosciences Pty Ltd.
- First posted
- Jan 13, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 1 month, up to 24 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
VICTOR is a randomized, double-blind, placebo-controlled, multicenter, 2-part study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and antiviral effect of single and multiple dosing of AK0529 in infants hospitalized with RSV infection.
Conditions
- RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Interventions
AK0529Drug
AK0529 is a novel compound being developed for the treatment of RSV infection. The enteric coated drug pellets with sugar core can be administered orally with apple sauce/purée or yoghurt, or by flushing with 10% dextrose water via a nasogastric or other feeding tube, or upon a glucose wafer.
PlaceboDrug
The placebo was made with the same smell and appearance as AK0529 but without the active ingredients. The placebo supplements are composed primarily of microcrystaline cellulose pellet.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Adverse Events during the studyTime frame: Day -4 to single dose Day 7 (Part 1) and Day -3 to multiple dose Day 14 (Part 2)
- Subject withdrawals due to Adverse EventsTime frame: Day -4 to single dose Day 7 (Part 1) and Day -3 to multiple dose Day 14 (Part 2)
Locations
28 sites in 8 countries. Site status is shown where the registry gives one.
Gold Coast University Hospital
Gold Coast, Queensland, Australia
Lady Cilento Children's Hospital
South Brisbane, Queensland, Australia
Women's and Children's Hospital
Adelaide, South Australia, Australia
Prince of Wales Hospital
Shatin, Hong Kong
Soroka University Medical Center
Beersheba, Israel
Ruth Rappaport Children's Hospital
Haifa, Israel
Schneider Children's Medical Center
Petach Tikvah, Israel
American University of Beirut Medical Center
Beirut, Lebanon
Makassed General Hospital
Beirut, Lebanon
Rafik Hariri University Hospital
Beirut, Lebanon
Saint George Hospital University Medical Center
Beirut, Lebanon
University Malaya Medical Center
Kuala Lumpur, Malaysia
Hospital Tuanku Jaafar
Seremban, Negeri Sembilan, Malaysia
Hospital Sibu
Sibu, Sarawak, Malaysia
Hospital Selayang
Batu Caves, Selangor, Malaysia
Hospital Tengku Ampuan Rahimah
Klang, Selangor, Malaysia
Specjalistyczny Zespół Opieki Zdrowotnej nad Matką i Dzieckiem w Poznaniu
Poznan, Greater Poland Voivodeship, Poland
Nowy Szpital w Świeciu
Gmina Świecie, Kujawy-Pomerania, Poland
Szpital im. Świętej Jadwigi Śląskiej w Trzebnicy
Trzebnica, Trzebnica County, Poland
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan
Mackay Memorial Hospital
Taipei, Taiwan
National Taiwan University Hospital
Taipei, Taiwan
Taipei Municipal Wanfang Hospital
Taipei, Taiwan
Linkou Chang Gung Memorial Hospital
Taoyuan, Taiwan
Marmara University Faculty of Medicine
Istanbul, Turkey (Türkiye)
Cukurova University Balcali Hospital
Adana, Adana, Turkey (Türkiye)
Eskisehir Osmangazi University Faculty of Medicine
Eskişehir, Eskişehir, Turkey (Türkiye)
Ege University Medical Faculty
Izmir, İzmir, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.